KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Receivables (2016 - 2025)

Historic Receivables for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $73.3 million.

  • Dynavax Technologies' Receivables fell 259.84% to $73.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $73.3 million, marking a year-over-year decrease of 259.84%. This contributed to the annual value of $46.9 million for FY2024, which is 532.86% up from last year.
  • Dynavax Technologies' Receivables amounted to $73.3 million in Q3 2025, which was down 259.84% from $73.3 million recorded in Q2 2025.
  • Dynavax Technologies' Receivables' 5-year high stood at $252.8 million during Q3 2021, with a 5-year trough of $44.5 million in Q4 2023.
  • Its 5-year average for Receivables is $97.3 million, with a median of $75.3 million in 2024.
  • Per our database at Business Quant, Dynavax Technologies' Receivables surged by 1162757.48% in 2021 and then crashed by 7948.69% in 2023.
  • Over the past 5 years, Dynavax Technologies' Receivables (Quarter) stood at $178.7 million in 2021, then grew by 21.46% to $217.1 million in 2022, then plummeted by 79.49% to $44.5 million in 2023, then grew by 5.33% to $46.9 million in 2024, then soared by 56.31% to $73.3 million in 2025.
  • Its Receivables stands at $73.3 million for Q3 2025, versus $73.3 million for Q2 2025 and $56.6 million for Q1 2025.